Indications |
Oral Type 2 diabetes mellitus Adult: Initially, 25 mg tid, to be taken at the start (with the 1st bite) of each main meal. Increase if necessary after 4-8 wk to usual maintenance dose 50 mg tid. Max dose 100 mg tid. |
Contraindications |
Renal clearance <25 ml/min, GI motility disorders or the presence of inflammatory bowel disease, diabetic ketoacidosis, colonic ulceration, or partial intestinal obstruction. Lactation. |
Warnings / Precautions |
Hypoglycaemia, renal impairment. |
Adverse Reactions |
Abdominal pain, diarrhoea, flatulence, skin rash. To minimise GI effects, treatment may be initiated at 25 mg once daily and increased gradually to three times daily. |
Drug Interactions |
Miglitol may significantly reduce the bioavailability of ranitidine and propranolol. Intestinal adsorbents (e.g, charcoal) and digestive enzyme preparations containing carbohydrate-splitting enzymes (e.g, amylase, pancreatin) may reduce the effect and should not be taken concomitantly. See Below for More miglitol Drug Interactions |
Mechanism of Actions |
Miglitol inhibits of alpha-glucosidase enzymes present in the intestine. It delays carbohydrate metabolism, decreases carbohydrate absorption, and thereby smoothens the postprandial increase in plasma glucose. Absorption: Absorption from GI tract is saturable at high doses. Peak concentrations reached in 2-3 hr. Distribution: <4% protein bound Excretion: Eliminated in the urine as unchanged drug. Elimination half life is around 2 hr. |
Administration |
Should be taken with food. (Take w/ 1st bite of each main meal.) |
Storage Conditions |
Oral: Store at 15-30°C |
ATC Classification |
A10BF02 - miglitol ; Belongs to the class of alpha glucosidase inhibitors. Used in the treatment of diabetes. |
Storage |
Oral: Store at 15-30°C |
Available As |
|
Miglitol
Post Review about Miglitol Click here to cancel reply.
Miglitol Containing Brands
Miglitol is used in following diseases
Drug - Drug Interactions of Miglitol
Latest News
- FDA approves Ruconest for treatment of hereditary angioedema
- FDA recommend against aspirin to prevent First Heart Attacks
- FDA approves Pomalyst (pomalidomide) for advanced multiple myeloma
- FDA approves three new drug treatments for type 2 diabetes
- Long-term consequences of vaginal delivery on the pelvic floor
No comments yet.